His work focuses on legacy-to-modern platform migration, data and integration modernization, re-architecting compliance, data ...

Lilly’s success in diabetes and weight management has been transformative, establishing it as a leader in one of the ...

BioAtla’s Q3 2025 update details FDA-aligned Oz-V Phase III trial, peak sales forecast, strategic deal progress, and cost reductions.

The next big advantage isn’t just AI — it’s smarter leadership. CXO 3.0 is where confidence, trust and intelligence drive ...

P3 Health Partners Inc. (NASDAQ: PIII) Q3 2025 Earnings Call Transcript November 14, 2025 P3 Health Partners Inc. misses on ...

Lifeward Ltd. is reaffirming full-year 2025 guidance, including expected revenue in the range of $24 million to $26 million ...

Q2 2026 Earnings Call Transcript November 13, 2025 Quantum Corporation misses on earnings expectations. Reported EPS is $-0.54 EPS, expectations were $-0.25. Operator: Ladies and gentlemen, greetings, ...

Sera Prognostics, Inc. ( SERA) Q3 2025 Earnings Call November 13, 2025 5:00 PM EST Good afternoon, and welcome to the Sera Prognostics Conference Call to review third quarter fiscal year 2025 results.

Q3 2025 Earnings Call Transcript November 14, 2025 Lifeward Ltd. beats earnings expectations. Reported EPS is $-0.01979, expectations were $-0.14. Operator: Good morning, and welcome to the Third ...

Occidental Petroleum Corp (OXY) — The company expects flat to 2% production growth in 2026, with capital spending projected to decline to $6.3–$6.7 billion from the 2025 range of $7.1–$7.3 billion.

StarHub’s four-pillar strategy is driving disciplined execution, digital innovation and long-term value creation for ...

Positive 15%, marking a sequential and year-over-year improvement, supported by reduced product costs and a net reduction in ...